2International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes [J]. Diabetes Care, 2009,32 : 1327-1334.
3Stratton IM, Alder AI, Nell HA, et al. Association of glycaemic with macrovascular and microvascular complications of type 2 dia- betes ( UKPDS 35 ) : prospective observational study [ J ]. BMJ, 2000,321 (7258) :405-412.
4Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual he- moglobin in patients with diabetes mellitus[J]. Biochem Biophys Res Commun,1969,36(5) :838-843.
5Kutter D,Thoma J. Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin[J]. Clin Lab, 2006,52 (9-10) : 477-481.
6Asia-Pacific Type 2 Diabetes Policy Group. Type 2 diabetes prac tical targets and Treatment. 4th ed. Sydney: Health Communications Australia Pty Ltd and In Vivo Communications Pty Ltd, 2005.
7Little RR,Rohlfing CL,Wiedmeyer HM, et al. The National Gly- cohemoglobin Standardization Program..A Five-Year Progress Report[J]. Clin Chem,2001,47:1985-1992.
8Bunn FH, Forget BG. Hemoglobin: molecular, genetic and clinical aspects[J]. Philadelphia : WB Saunders Co, 1986 : 425-427.
9Little RR,Roberts WL. A review of variant hemoglobins interfering with hemoglobin Ale measurement[J]. J Diabetes Sci Technol,2009,3(3) :446-451.
10Camargo JL, Felisberto M,Gross JL. Effect of pre analytical vari ables on glycohemoglobin measurements in routine clinical care [J]. Clin Biochem,2004,37(9) :836-839.
